Nucleus has listed on the Alternative Investment Market (AIM) at an expected market capitalisation of £140m.
Dealing on the platform company's shares begun at 8am on Thursday at a placing price of 183p. The gross proceeds of the listing receivable by the selling shareholders could be more than £32m. The firm, which has more than £14bn assets under administration, said 22.9% of the issued ordinary share capital was sold pursuant to the placing. "This is an important milestone as we continue our work to support and promote the strategic alignment of advisers and their customers," said chief executive David Ferguson (pictured). "It's great to see so many institutional investors believing in th...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes